News

Pharma Biotools VC Trends

June 5, 2025/

PitchBook
Pharma biotools funding surges in Q1 2025 led by AI and synthetic biology platformsVC investment in pharma biotools rebounded strongly in Q1 2025, showing significant increases in both funding and deal count. This quarter represented the highest funding level since Q2 2024, with trailing 12-month funding demonstrating robust YoY growth despite broader market consolidation pressures.

Key investment trends:


Click here to read the story.

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

Sorry, we couldn't find any posts. Please try a different search.

MATR Supporters (view all)


Montana Bioscience Cluster Initiative - Collaborative program design and execution and integrated programs fostering innovation, technology commercialization, entrepreneurship and sustainable small businesses

For over 25 years, Zoot Enterprises has been a global provider of advanced origination, acquisition, and decision management solutions.

Bozeman is a rapidly growing city with a high quality of life in part due to the easy access to the outdoors, burgeoning tech industry, and cultural experiences it offers.